COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Click to access mobile menu
Print
  • Share:
Skip Navigation LinksHome > Programs and Activities > ODS Seminars, Conferences, and Workshops > Special Issue on Psychoactive Botanical Products

Notice: Historical Content
This is an archival or historical document and may not reflect current data.

Special issue on Psychoactive Botanical Products. Pharmacology & Therapeutics. 2004 May;102(2):97-138.

Abstracts (access to complete journal articles requires subscription)

Coates PM, Chausmer A.external link disclaimer Introduction. Pharmacol Ther. 2004 May;102(2):97-8. No abstract available.

Roth BL, Lopez E, Beischel S, Westkaemper RB, Evans JM.external link disclaimer Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. Pharmacol Ther. 2004 May;102(2):99-110.

McKenna DJ.external link disclaimer Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
Pharmacol Ther. 2004 May;102(2):111-29.

Halpern JH.external link disclaimer Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther. 2004 May;102(2):131-8.